Target RWE Teams Up with AASLD to Improve Outcomes for Cirrhosis Patients

Target RWE, a leader in real-world evidence (RWD) and observational research, is starting a new collaboration with the American Association for the Study of Liver Diseases (AASLD). Through this partnership, Target RWE will help the organization with its Cirrhosis Quality Collaborative (CQC), which aims to improve healthcare quality and outcomes for patients with cirrhosis through data analytics.

According to Target RWE, “The partnership combines the established CQC network with the strength of Target RWE’s data collection and analytics capabilities to advance progress in research and improve the quality of care in patients with liver disease. This will be accomplished by aggregating data generated directly as part of clinical care on thousands of patients from multiple centers across the United States. Participating clinical sites and teams will be networked with AASLD and Target RWE as a part of a longer-term growth initiative under the TARGET-Liver Disease (LD) protocol.”

To read more, click here.

(Source: Yahoo, October 18^th, 2022)